UpHealth, Inc. reaffirmed earnings guidance for fiscal 2022. For the full year 2022, the Company continues to expect total revenue between $205 and $233 million, a 38-56% growth rate, gross margins of 42% to 43% and adjusted EBITDA of $14 to $19 million.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5497 USD | +2.19% | -6.03% | +139.52% |
03-21 | UpHealth, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-21 | UpHealth, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+139.52% | 10.03M | |
-9.04% | 24.98B | |
+18.48% | 22.52B | |
-4.86% | 2.34B | |
+99.74% | 2.14B | |
-19.23% | 2.01B | |
-40.22% | 1.87B | |
-18.76% | 1.31B | |
-0.36% | 1.28B | |
-2.86% | 1.25B |
- Stock Market
- Equities
- UPHL Stock
- News UpHealth, Inc.
- UpHealth, Inc. Reaffirms Earnings Guidance for Fiscal 2022